"PrEP Delays HIV Detection In Seroconverters But Does Not Boost Resistance Risk" - Marilynn Larkin
Continuing pre-exposure prophylaxis in HIV seroconverters may delay HIV infection detection but does not increase drug resistance, researcher report. Antonio Urbina, MD, associate professor of medicine and infectious disease at the Icahn School of Medicine at Mount Sinai said, “This study is reassuring in showing that rates of drug resistance do not increase patients who continue on PrEP during seroconversion.” More importantly, “viral load levels for seroconverters on PrEP versus placebo were up to 1,000 times lower, implying that patients who remain on PrEP would be significantly less infectious and hence less likely to transmit,” Dr. Urbina added.
- Antonio Urbina, MD, Associate Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai